Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,843,663,968
New position
Shares Held
19,489,220
first reported quarter
Ownership
1.26%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 98.34432573494475.ToString("F0")%
Shared 0.ToString("F0")%
None 1.6556742650552458.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $32,740,779,918 across 15 Drug Manufacturers - General names. AZN ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,992,224 | $12,869,627,867 | |
| 2 | JNJ |
Johnson & Johnson
|
16,491,133 | $4,031,092,550 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
19,489,220 | $3,843,663,968 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
26,248,108 | $3,658,198,811 | |
| 5 | ABBV |
AbbVie Inc.
|
13,003,989 | $2,828,237,567 | |
| 6 | MRK |
Merck & Co., Inc.
|
23,042,842 | $2,771,823,463 | |
| 7 | AMGN |
Amgen Inc
|
1,867,189 | $656,970,449 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
10,250,238 | $621,676,934 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,843,663,968 | 19,489,220 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||